课题基金 / 基金详情

HIF1a正向调控SLIT3在BMP9促进MSCs成骨分化与血管形成中的作用与机制研究

批准号:
82072443
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
胡宁
依托单位:
学科分类:
骨、关节、软组织损伤与修复
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
胡宁

项目摘要

结项摘要

胡宁的其他基金

相似基金

相关文献

中文摘要
BMP9是诱发成骨分化和血管形成的关键分子,探究其调控细节具有重要意义。课题组前期发现BMP9通过磷酸化Smad1/5/8上调HIF1α,HIF1α进一步正向调控Runx2,促进成骨与血管形成,显示HIF1α是成血管、成骨级联反应共同起始调节因子。而抑制Runx2不能完全抑制HIF1α的双向效应,提示该效应仍存在尚不清楚的分子机制。RNA测序发现BMP9和HIF1α显著上调神经轴突导向分子(SLIT3)表达,ChIP提示HIF1α与SLIT3启动子具有结合能力。因此,我们提出假说:HIF1α正向调控SLIT3,在协调BMP9促进成骨与血管形成效应中具有重要作用。本项目拟采用体内外实验,对HIF1α正向调控SLIT3的作用及其在调控BMP9促进MSCs成骨分化与血管形成的作用和分子机制进行深入研究。本研究不仅对于拓展骨发育生物学基础理论具有重要意义,而且对于治疗相关骨科疾病提供新的视角。
英文摘要
BMP9 is a key regulator that induces osteogenic differentiation and angiogenesis, with importance attached to exploring its regulatory functions. Our research team found that BMP9 up-regulates hypoxia-inducible factor 1α (HIF1α) through phosphorylation of Smad1/5/8, and HIF1α further directly regulates Runx2, resulting in bidirectional effect between osteogenesis and angiogenesis. These effects demonstrated that HIF1α is a co-initial regulator in the cascade responses between osteogenesis and angiogenesis. It was found that the bidirectional effect of HIF1α could not be completely inhibited after Runx2 was inhibited, which suggests that the molecular mechanism between osteogenesis and angiogenesis remains unclear. RNA sequencing revealed that BMP9 and HIF1α could significantly potentiate the expression of SLIT guidance ligand 3 (SLIT3), ChIP assay suggested that transcription factor HIF1α is capable of binding the promoter of SLIT3. Thus, we propose a hypothesis that the key regulator HIF1α positively regulates SLIT3 and plays an essential role in coordinating BMP9; to promote the coupling effects between osteogenesis and angiogenesis. This project intends to use in vivo and in vitro experiments to further study the effects of HIF1α in positively regulating SLIT3 and to investigate the possible molecular mechanism and signaling pathways, regulating the BMP9 induced coupling effects of osteoblastic differentiation and angiogenesis of MSCs. This project possesses great potential, not only for significantly expanding the basic theory of bone development and bone biology, but also in providing a new perspective on the treatment of related orthopedic diseases.
BMP9是诱发成骨分化和血管形成的关键分子,探究其调控细节具有重要意义。课题组前期,发现BMP9通过磷酸化Smad1/5/8上调HIF1α,HIF1α进一步正向调控Runx2,促进成骨与血管形成,显示HIF1α是成血管、成骨级联反应共同起始调节因子。而抑制Runx2不能完全抑制HIF1α的双向效应,提示该效应仍存在尚不清楚的分子机制。RNA测序发现BMP9和HIF1α显著上调神经轴突导向分子(SLIT3)表达,ChIP提示HIF1α与SLIT3启动子具有结合能力。因此,我们提出假说:HIF1α正向调控SLIT3,在协调BMP9促进成骨与血管形成效应中具有重要作用。本项目拟采用体内外实验,对HIF1α正向调控SLIT3的作用及其在调控BMP9促进MSCs成骨分化与血管形成的作用和分子机制进行深入研究。本研究不仅对于拓展骨发育生物学基础理论具有重要意义,而且对于治疗相关骨科疾病提供新的视角。
HLA负向调控巨噬细胞Cofilin-Actin-Drp1复合体致线粒体分裂抑制在金葡菌实现胞内存活的作用和机制研究
  • 批准号:
    82372425
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    胡宁
  • 依托单位:
可注射水凝胶微球负载高靶向性声响应型四羧基苯基卟啉脂质体治疗金葡菌胞内感染研究
  • 批准号:
    CSTB2023NSCQ-MSX0166
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2023
  • 负责人:
    胡宁
  • 依托单位:
HIF1α与Runx2在调控BMP9促进间充质干细胞成骨分化与血管形成双向效应中的作用和分子机制研究
  • 批准号:
    81672167
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2016
  • 负责人:
    胡宁
  • 依托单位:
国内基金
海外基金